Neuro-endocrine tumours, therapy is decided in a group
Still difficult to diagnose and very heterogeneous from a clinical and biological point of view, neuroendocrine tumors are a group...
Still difficult to diagnose and very heterogeneous from a clinical and biological point of view, neuroendocrine tumors are a group...
A topical gene therapy against a rare skin disease. It is distributed in drops of gel over the lesions, in...
About 3,300 Italians are affected each year by acute myeloid leukemia, a particularly aggressive blood cancer. Of these, about 40%...
Acupuncture helps to soothe disorders related to female tumors (uterus, ovary, breast) and traditional treatments. We are not talking about...
It is a rare cholestatic liver disease that is making headlines today thanks to positive results from the Phase 3...
Francesca is 16 years old, tall, thin and beautiful, studying at the classical high school and comes from a wealthy...
Thanks to a new hypomethylating drug, oral azacitidine, able to improve survival by reducing the probability of recurrence, today the...
The first 'attack' on the disease is crucial because everything else depends on how the body responds, but maintenance therapy...
An ultra-rare chronic disease, which mainly affects young people between 20 and 35 years of age and which often manifests...
The news comes from Frankfurt, where the annual Congress of the European Hematology Association (EHA) is underway, that a 6-year-old...
Car-T therapy has radically changed the outlook for some serious blood cancer patients. A small slice of patients, to tell...
They have a frightening name because it refers to something difficult to understand: they are tumors with TRK fusion that...
The drug-conjugated antibody trastuzumab deruxtecan, now used in a particular type of metastatic breast cancer, also appears to be effective...
Metastatic prostate cancer resistant to testosterone-suppressing drugs, associated with the development of the tumor, is the most difficult to treat...
From the Asco (American Society of Clinical Oncology) congress, underway in Chicago, comes an important novelty for the treatment of...